"Early" and "definitive" taking charge of subjects positive to SARS-CoV2: the experience of an Italian Local Health Authority von De Polo, A, Facchin, G, Battistin, M, Pais Dei Mori, L, Nassiz, P, D'Alfonso, M, Rizzardini, J, Stevanato, M, Zanghi, F, Leone, E, Cinquetti, S

Volltext

Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression von Swindells, Susan, Andrade-Villanueva, Jaime-Federico, Richmond, Gary J, Rizzardini, Giuliano, Baumgarten, Axel, Masiá, Mar, Latiff, Gulam, Pokrovsky, Vadim, Bredeek, Fritz, Smith, Graham, Cahn, Pedro, Kim, Yeon-Sook, Ford, Susan L, Talarico, Christine L, Patel, Parul, Chounta, Vasiliki, Crauwels, Herta, Parys, Wim, Vanveggel, Simon, Mrus, Joseph, Huang, Jenny, Harrington, Conn M, Hudson, Krischan J, Margolis, David A, Smith, Kimberly Y, Williams, Peter E, Spreen, William R

Volltext

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV von Ferenci, Peter, Bernstein, David, Lalezari, Jacob, Cohen, Daniel, Luo, Yan, Cooper, Curtis, Tam, Edward, Marinho, Rui T, Tsai, Naoky, Nyberg, Anders, Box, Terry D, Younes, Ziad, Enayati, Pedram, Green, Sinikka, Baruch, Yaacov, Bhandari, Bal Raj, Caruntu, Florin Alexandru, Sepe, Thomas, Chulanov, Vladimir, Janczewska, Ewa, Rizzardini, Giuliano, Gervain, Judit, Planas, Ramon, Moreno, Christophe, Hassanein, Tarek, Xie, Wangang, King, Martin, Podsadecki, Thomas, Reddy, K. Rajender

Volltext

Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials von Rizzardini, Giuliano, Overton, Edgar T., Orkin, Chloe, Swindells, Susan, Arasteh, Keikawus, Górgolas Hernández-Mora, Miguel, Pokrovsky, Vadim, Girard, Pierre-Marie, Oka, Shinichi, Andrade-Villanueva, Jaime F., Richmond, Gary J., Baumgarten, Axel, Masiá, Mar, Latiff, Gulam, Griffith, Sandy, Harrington, Conn M., Hudson, Krischan J., St. Clair, Marty, Talarico, Christine L., Patel, Parul, Cutrell, Amy, Van Eygen, Veerle, D'Amico, Ronald, Mrus, Joseph M., Wu, Sterling, Ford, Susan L., Chow, Ken, Roberts, Jeremy, Wills, Angela, Walters, Nicola, Vanveggel, Simon, Van Solingen-Ristea, Rodica, Crauwels, Herta, Smith, Kimberly Y., Spreen, William R., Margolis, David A.

Volltext

Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains HIV-1 Virologic Suppression Through 48 Weeks: Results of the DRIVE-SHIFT Trial von Johnson, Margaret, Kumar, Princy, Molina, Jean-Michel, Rizzardini, Giuliano, Cahn, Pedro, Bickel, Markus, Mallolas, Josep, Zhou, Yan, Morais, Cristiana, Kumar, Sushma, Sklar, Peter, Hanna, George J, Hwang, Carey, Greaves, Wayne

Volltext

Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-infer... von Overton, Edgar T, Richmond, Gary, Rizzardini, Giuliano, Jaeger, Hans, Orrell, Catherine, Nagimova, Firaya, Bredeek, Fritz, García Deltoro, Miguel, Swindells, Susan, Andrade-Villanueva, Jaime Federico, Wong, Alexander, Khuong-Josses, Marie-Aude, Van Solingen-Ristea, Rodica, van Eygen, Veerle, Crauwels, Herta, Ford, Susan, Talarico, Christine, Benn, Paul, Wang, Yuanyuan, Hudson, Krischan J, Chounta, Vasiliki, Cutrell, Amy, Patel, Parul, Shaefer, Mark, Margolis, David A, Smith, Kimberly Y, Vanveggel, Simon, Spreen, William

Volltext

Single Tablet Regimen Usage and Efficacy in the Treatment of HIV Infection in Australia von Fagan, D., Stewart, M. J., Chan, D. J., Armstrong, B., Smith, D.

Volltext

Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection von Kozal, Michael, Aberg, Judith, Pialoux, Gilles, Cahn, Pedro, Thompson, Melanie, Molina, Jean-Michel, Grinsztejn, Beatriz, Diaz, Ricardo, Castagna, Antonella, Kumar, Princy, Latiff, Gulam, DeJesus, Edwin, Gummel, Mark, Gartland, Margaret, Pierce, Amy, Ackerman, Peter, Llamoso, Cyril, Lataillade, Max

Volltext

Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the "COPA" pilot randomized trial von Gori, A, Rizzardini, G, van't Land, B, Amor, K B, van Schaik, J, Torti, C, Quirino, T, Tincati, C, Bandera, A, Knol, J, Benlhassan-Chahour, K, Trabattoni, D, Bray, D, Vriesema, A, Welling, G, Garssen, J, Clerici, M

Volltext

Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel von Thompson, Melanie A, Aberg, Judith A, Hoy, Jennifer F, Telenti, Amalio, Benson, Constance, Cahn, Pedro, Eron, Joseph J, Günthard, Huldrych F, Hammer, Scott M, Reiss, Peter, Richman, Douglas D, Rizzardini, Giuliano, Thomas, David L, Jacobsen, Donna M, Volberding, Paul A

Volltext

Multiclass HCV resistance to direct‐acting antiviral failure in real‐life patients advocates for tailored second‐line therapies von Di Maio, Velia C., Cento, Valeria, Aragri, Marianna, Rossi, Piera, Verucchi, Gabriella, Magni, Carlo F., Teti, Elisabetta, Micheli, Valeria, Calvaruso, Vincenza, Gianserra, Laura, Romagnoli, Dante, Cozzolongo, Raffaele, Grieco, Antonio, Morisco, Filomena, Brancaccio, Giuseppina, Di Biagio, Antonio, Loggi, Elisabetta, Mastroianni, Claudio M., Pace Palitti, Valeria, Tarquini, Pierluigi, Puoti, Massimo, Vullo, Vincenzo, Paoloni, Maurizio, Pasquazzi, Caterina, Rizzardini, Giuliano, Parruti, Giustino, Craxì, Antonio, Babudieri, Sergio, Angelico, Mario, Ceccherini‐Silberstein, Francesca, Grimaldi, A., Verucchi, G., Menzaghi, B., Quirino, T., Torti, C., Vecchiet, J., Bruzzone, B., De Maria, A., Marenco, S., Viscoli, C., Lichtner, M., Aghemo, A., Boccaccio, V., Bruno, S., Cerrone, M., Colombo, M., Danieli, E., Donato, F., Gubertini, G., Lleo, A., Magni, C.F., Mancon, A., Monico, S., Gnocchi, M., Orro, A., Milanesi, L., Bertolotti, M., Borghi, V., Mussini, C., Gaeta, G.B., Sangiovanni, V., Di Marco, V., Mazzola, A., D'Amico, E., Cacciatore, P., Consorte, A., Pieri, A., Sozio, F., Baiocchi, L., Barbaliscia, S., Biliotti, E., Carioti, L., Cerasari, G., Cerva, C., Ciotti, M., D'Ettorre, G., De Leonardis, F., De Sanctis, A., Di Maio, V.C., Furlan, C., Gallo, P., Giannelli, V., Lattanzi, B., Lenci, I., Lula, R., Malagnino, V., Manuelli, M., Milana, M., Moretti, A., Palazzo, D., Pellicelli, A., Romano, M., Sarrecchia, C., Sorbo, M.C., Spaziante, M., Mangia, A., Maida, I., Mura, M.S., Falconi, L., Di Giammartino, D.

Volltext

Long-Acting Injectable Cabotegravir plus Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials von Rizzardini, Giuliano, Overton, Edgar T., Orkin, Chloe, Swindells, Susan, Arasteh, Keikawus, Gorgolas Hernandez-Mora, Miguel, Pokrovsky, Vadim, Girard, Pierre-Marie, Oka, Shinichi, Andrade-Villanueva, Jaime F., Richmond, Gary J., Baumgarten, Axel, Masia, Mar, Latiff, Gulam, Griffith, Sandy, Harrington, Conn M., Hudson, Krischan J., St Clair, Marty, Talarico, Christine L., Patel, Parul, Cutrell, Amy, Van Eygen, Veerle, D'Amico, Ronald, Mrus, Joseph M., Wu, Sterling, Ford, Susan L., Chow, Ken, Roberts, Jeremy, Wills, Angela, Walters, Nicola, Vanveggel, Simon, Van Solingen-Ristea, Rodica, Crauwels, Herta, Smith, Kimberly Y., Spreen, William R., Margolis, David A.

Volltext

DarkSide-20k: A 20 tonne two-phase LAr TPC for direct dark matter detection at LNGS von Aalseth, C. E., Agnes, P., Albuquerque, I. F. M., Bettarini, S., Bisogni, M. G., Bottino, B., Boulay, M., Bunker, R., Cadeddu, M., Cadoni, M., Caravati, M., Cariello, M., Cicalò, C., Cocco, A. G., Colocci, M., Crivelli, P., D’Antone, I., Davini, S., De Cecco, S., De Rosa, G., Demontis, P., Di Eusanio, F., Di Pietro, G., Dionisi, C., Dolgov, A., Empl, A., Fiorillo, G., Gabriele, F., Gabrieli, A., Garcia Abia, P., Ghisi, A., Giagu, S., Giganti, C., Giovanetti, G. K., Grigoriev, G. Y., Guan, M., Guerzoni, M., Hallin, A., Harrop, B., Horikawa, S., Hungerford, E. V., Johnson, T. N., Lehnert, B., Li, X., Luzzi, L., Mandarano, A., Mapelli, L., Marcante, M., Margotti, A., Maricic, J., Mayer, M., Monroe, J., Monte, A., Morrocchi, M., Mount, B. J., Musico, P., Nania, R., Nosov, V., Oleynikov, V., Ortica, F., Pallavicini, M., Pantic, E., Pelczar, K., Perotti, F., Perruzza, R., Piemonte, C., Pocar, A., Pollmann, T., Portaluppi, D., Pugachev, D. A., Qian, H., Ragusa, F., Regazzoni, V., Romani, A., Rubbia, A., Salatino, P., Sánchez García, E., Sanfilippo, S., Savarese, C., Segreto, E., Shchagin, A., Singh, P. N., Smirnov, O., Sokolov, A., Sotnikov, A., Suvorov, Y., Testera, G., Tonazzo, A., Unzhakov, E. V., Vacca, A., Vázquez-Jáuregui, E., Vogelaar, B., Wahl, J., Wang, Y., Williams, R., Wu, S., Xiao, X., Yang, C., Zhu, C., Zullo, A.

Volltext

Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254 von Spinner, Christoph D, Felizarta, Franco, Rizzardini, Giuliano, Philibert, Patrick, Mitha, Essack, Domingo, Pere, Stephan, Christoph J, DeGrosky, Michelle, Bainbridge, Veronica, Zhan, Joyce, Dumitrescu, Teodora Pene, Jeffrey, Jerry L, Xu, Jianfeng, Halliday, Fiona, Gan, Jianjun, Johnson, Mark, Gartland, Martin, Joshi, Samit R, Lataillade, Max

Volltext

Effectiveness of dolutegravir‐based regimens as either first‐line or switch antiretroviral therapy: data from the Icona cohort von Tavelli, Alessandro, Rusconi, Stefano, Vichi, Francesca, Ceccherini‐Silberstein, Francesca, Marchetti, Giulia, d'Arminio Monforte, Antonella, Castelli, F, Cauda, R, Di Perri, G, Galli, M, Iardino, R, Ippolito, G, azzarin, A, Rezza, G, Schloesser, F, Viale, P, Cozzi‐Lepri, A, Girardi, E, Lo Caputo, S, Mussini, C, Puoti, M, Perno, CF, Balotta, C, Bandera, A, Bonora, S, Capetti, A, Cicalini, S, Cinque, P, Gianotti, N, Gori, A, Lapadula, G, Lichtner, M, Madeddu, G, Monno, L, Quiros Roldan, E, Rossotti, R, Rusconi, S, Santoro, MM, Galli, L, Lorenzini, P, Macchia, M, Tavelli, A, Carletti, F, Carrara, S, Di Caro, A, Graziano, S, Petrone, F, Truffa, S, Giacometti, Italy A, Fabrizio, C, Suardi, C, i, V, Verucchi, G, Castelnuovo, F, Menzaghi, B, Abeli, C, Celesia, B, Vecchiet, J, Falasca, K, Pan, A, Lorenzotti, S, Sighinolfi, L, Blanc, P, Viscoli, C, lessandrini, A, Mazzarello, G, Pozzetto, I, Bonfanti, P, Milini, P, Rizzardini, G, Bai, F, Ridolfo, AL, Salpietro, S, Tincati, C, Sangiovanni, V, Borgia, G, Esposito, V, Di Martino, F, Gentile, I, Cattelan, AM, Marinello, S, Baldelli, F, Parruti, G, Vullo, V, Baldin, G, Capozzi, M, Iaiani, G, atini, A, Vergori, A, Cecchetto, M, Viviani, F, Rossetti, B, Francisci, D, Di Giuli, C, Caramello, P, Orofino, GC, Bassetti, M, Pellizzer, G, Starnini, G, alungo, A

Volltext

Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two m... von Eron, Joseph J, Prof, Young, Benjamin, MD, Cooper, David A, Prof, Youle, Michael, MD, DeJesus, Edwin, MD, Andrade-Villanueva, Jaime, MD, Workman, Cassy, MD, Zajdenverg, Roberto, MD, Fätkenheuer, Gerd, Prof, Berger, Daniel S, MD, Kumar, Princy N, MD, Rodgers, Anthony J, MS, Shaughnessy, Melissa A, MS, Walker, Monica L, BS, Barnard, Richard JO, PhD, Miller, Michael D, PhD, DiNubile, Mark J, MD, Nguyen, Bach-Yen, MD, Leavitt, Randi, MD, Xu, Xia, PhD, Sklar, Peter, Dr

Volltext

Cytomegalovirus Coinfection Is Associated With an Increased Risk of Severe Non-AIDS-Defining Events in a Large Cohort of HIV-Infected Patients von Lichtner, Miriam, Cicconi, Paola, Vita, Serena, Cozzi-Lepri, Alessandro, Galli, Massimo, Lo Caputo, Sergio, Saracino, Annalisa, De Luca, Andrea, Moioli, Mariacristina, Maggiolo, Franco, Marchetti, Giulia, Vullo, Vincenzo, Montarte, Antonella d'Arminio

Volltext

135. Piloting a Quality Improvement Package for Adolescent Sexual and Reproductive Health Care in Community Health Centers: Getting to Quality for Teens (Q4T) von Brittain, Anna W., Steiner, Riley J., Hatfield-Timajchy, Kendra, Tadikonda, Ananya, Bernstein, Caryn, McLaurin, Jennie, Bobrow, Mikayla, Douglas, Alice, Dobreff, Stacy, Irizarry, Glorimar, Lekakis, Despina, Rice, Jane, Rizzardini, Johanna, Skorupa, Annie, Zuidersma, Dee

Volltext

Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 96-week results: a randomised, multicentre, open-label, phase 3b, non-infer... von Jaeger, Hans, Overton, Edgar T, Richmond, Gary, Rizzardini, Giuliano, Andrade-Villanueva, Jaime Federico, Mngqibisa, Rosie, Hermida, Antonio Ocampo, Thalme, Anders, Belonosova, Elena, Ajana, Faïza, Benn, Paul D, Wang, Yuanyuan, Hudson, Krischan J, Español, Carlos Martín, Ford, Susan L, Crauwels, Herta, Margolis, David A, Talarico, Christine L, Smith, Kimberly Y, van Eygen, Veerle, Van Solingen-Ristea, Rodica, Vanveggel, Simon, Spreen, William R

Volltext

Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised,... von Cahn, Pedro, Sax, Paul E, Squires, Kathleen, Molina, Jean-Michel, Ratanasuwan, Winai, Rojas, Evelyn, Rassool, Mohammed, Vandekerckhove, Linos, Yazdanpanah, Yazdan, Katlama, Christine, Xu, Xia, East, Lilly, Wenning, Larissa, Rawlins, Sandy, Cahn, PE, Roth, N, McMahon, J, Moore, RJ, Smith, D, Clumeck, N, Vanderkerckhove, L, Moutschen, M, Baril, J, Smith, GHR, Walmsley, SL, Perez, C, Katlama, C, Durant, J, Ajana, F, Faetkanheuer, G, Esser, S, Jaeger, H, Degen, O, Bickel, M, Bogner, J, Arasteh, K, Hartl, H, Rojas, EM, Gonzalez, LD, Mejia, CR, Levy, I, Sthoeger, Z, Monforte, A D'Arminio, Di Perri, G, Lazzarin, A, Celesia, BM, Maggiolo, F, Lee, CKC, Mustafa, M, Oyanguren, M, Castillo, RA, Hercilla, L, Echiverri, C, da Cunha, JG Saraiva, Neves, I, Teofilo, E, Nagimova, F, Sotnikov, V, Botes, ME, Kaplan, R, Gatell, JM, Negredo, E, Ortega, E, Aguirrebengoa, K, Antela, A, Calmy, A, Cavassini, M, Lin, HH, Tsai, HC, Changpradub, D, Avihingsanon, A, Kiertiburanakul, S, Ratanasuwan, W, Clarke, A, Ustianowski, A, Winston, A, Johnson, MA, Asmuth, DM, Cade, J, Gallant, JE, Ruane, PJ, Luque, AE, Panther, L, Tashima, KT, Ward, D, Berger, DS, Dietz, CA, Fichtenbaum, C, Mullane, KM, Novak, RM, Crofoot, GE, Hagins, DP, Lewis, ST, McDonald, CK, Sloan, L, Prelutsky, DJ, Ramirez, Santiago, L, Zorrilla, CD, Hsiao, CB

Volltext